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IL-27 is a heterodimeric cytokine consisting of 
the protein subunits IL27p28 and Epstein Barr 
virus–induced protein 3 (Pflanz et al., 2002).   
It signals through a heterodimeric receptor con-
sisting of the ligand-specific IL-27R chain and 
gp130 (Pflanz et al., 2004), which is shared with 
several other cytokines, including the structurally 
related cytokine IL-6. Like IL-6, IL-27 signaling 
involves  the  activation  of  Jak1,  STAT1,  and 
STAT3  (Batten  and  Ghilardi,  2007).  Despite 
shared use of the gp130 chain, the contribution 
of the IL-27R subunit makes IL-27 function-
ally  distinct  from  IL-6  in  that  it  promotes   
early aspects of TH1 differentiation, such as up-
regulation of the transcription factor T-bet and 
the IL-12 receptor 2 chain while suppress-
ing IL-6–driven T cell proliferation and TH17 
differentiation (Batten and Ghilardi, 2007).
In vivo, IL-27 acts to constrain inflamma-
tion under most circumstances that have been 
studied  to  date  (Batten  and  Ghilardi,  2007). 
Several possible mechanisms for this immuno-
suppressive activity have been identified; IL-27 
is  known  to  antagonize  TH17  development 
(Batten et al., 2006; Stumhofer et al., 2006), 
induce IL-10 production (Awasthi et al., 2007; 
Fitzgerald et al., 2007; Stumhofer et al., 2007; 
Batten et al., 2008), and suppress IL-6–induced 
T cell proliferation (Batten et al., 2006). Nev-
ertheless, IL-27 apparently plays a proinflam-
matory role in some situations. For example, 
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Maturation and selection of high-affinity B cell clones in the germinal center (GC) relies on 
support from T follicular helper (TFH) cells. TFH cells are characterized by their localization 
to the B cell follicle and their high expression of the costimulatory molecules ICOS and PD1 
and the cytokine IL-21, which promotes immunoglobulin (Ig) class switching and produc-
tion by B cells. We show that the heterodimeric cytokine IL-27 is critical for the function 
of TFH cells and for normal and pathogenic GC responses. IL-27 signaling to T cells results 
in the production of IL-21, a known autocrine factor for the maintenance of TFH cells, in a 
STAT3-dependent manner. IL-27 also enhances the survival of activated CD4+ T cells and 
the expression of TFH cell phenotypic markers. In vivo, expression of the IL-27R chain is 
required to support IL-21 production and TFH cell survival in a T cell–intrinsic manner. The 
production of high-affinity antibodies is reduced, and pristane-elicited autoantibodies and 
glomerulonephritis are significantly diminished, in Il27ra/ mice. Together, our data show 
a nonredundant role for IL-27 in the development of T cell–dependent antibody responses.
© 2010 Batten et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it  is  available  under  a  Creative  Commons  License  (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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We also found that the addition of rhIL-27 during stimu-
lation induced IL-21 expression by naive CD4+ T cells purified 
from human tonsil (Fig. 1 C) and peripheral blood (Fig. 1 D). 
These data suggest that IL-27 has a similar role in human and 
mouse IL-21 induction. In comparison to IL-27, IL-12 was a 
more potent IL-21 stimulant in cultures of human CD4+  
T cells (Fig. 1 C). Because IL-27 stimulation up-regulated 
the expression of IL-12R2 (Fig. S1 B), thereby sensitizing 
the cells to the effects of IL-12, these two cytokines may 
Il27ra/ mice are protected from proteoglycan-induced   
arthritis (Cao et al., 2008), which is dependent on both B and 
CD4+ T cell activity (Banerjee et al., 1992; Hamel et al., 
2008). Furthermore, deletion of Il27ra in the MRL/lpr model 
of lupus results in lower TH1 cytokine production, dimin-
ished anti-dsDNA antibodies, and enhanced survival (Shimizu 
et al., 2005). Together, these results suggest that IL-27 is re-
quired in proinflammatory situations that depend on genera-
tion of high-affinity antibodies in vivo.
Antibody  affinity  maturation  involves  the  selection  of   
antigen (Ag)-specific B cell clones that have undergone pro-
ductive somatic hypermutation. This occurs in germinal 
centers (GCs) in secondary lymphoid organs and relies on a 
specialized subset of CD4+ T helper cells termed T follicular 
helper (TFH) cells (Yu et al., 2009a). Without TFH cells, GCs 
are short lived and ineffective in generating high-affinity   
antibodies and B cell memory, whereas aberrant TFH activity 
can drive autoimmune disease (King, 2009; Yu et al., 2009a). 
TFH cells express CXCR5 and are thereby attracted to the 
GC by the B cell chemoattractant CXCL13. Concurrently, 
they down-regulate CCR7 which would otherwise retain 
them in the T cell zones. Besides being CXCR5+CCR7lo, 
TFH cells also express high levels of PD1 and ICOS (Yu et al., 
2009a) and low levels of CD127 (IL7R; Lim and Kim, 2007) 
and CD62L (Fazilleau et al., 2009). Bcl-6 has recently been 
shown to be a lineage-specific transcription factor, repressing 
alternative T helper cell differentiation pathways and pro-
moting TFH development (Johnston et al., 2009; Nurieva   
et al., 2009; Yu et al., 2009b). The requirements for TFH cell 
differentiation and maintenance are not fully understood but 
include sustained interactions with B cells (Haynes et al., 
2007) and ICOS-ICOSL signaling (Nurieva et al., 2008). 
Furthermore, TFH-derived IL-21 is known to provide crucial 
stimulation to B cells (Linterman et al., 2010; Zotos et al., 
2010) and can act as an autocrine growth factor for TFH cells 
(Nurieva et al., 2008; Vogelzang et al., 2008; Eddahri et al., 
2009; Linterman et al., 2010). In this paper, we identify IL-27 
as an essential cytokine for IL-21 induction, the function of 
TFH cells and GC responses, and show that the severity of   
antibody-mediated autoimmune disease is reduced in the ab-
sence of IL-27 signaling in a murine model of lupus.
RESULTS
IL-27 induces IL-21 expression in vitro and in vivo
We tested the effect of IL-27 on FACS-purified naive T cells 
during anti-CD3/anti-CD28 stimulation and found that the ad-
dition of IL-27 resulted in greatly elevated Il21 mRNA expres-
sion (Fig. 1 A), peaking at 24–48 h. This was a specific response 
to ligand–receptor interaction because no effect was observed   
on IL-27R–deficient (Il27ra/) T cells (Fig. 1 A). IL-27 was 
unable to significantly enhance IL-21 mRNA expression in the 
presence of the translational repressor cycloheximide (Fig. S1 A), 
suggesting that translation of intermediate proteins may mediate 
IL-21 expression. Analysis of the culture supernatants confirmed 
that IL-27 induces IL-21 protein production by >10-fold com-
pared with untreated cells by 48 h (Fig. 1 B).
Figure 1.  IL-27 induces IL-21 expression. (A) FACS-purified 
CD4+CD25 T cells isolated from either Il27ra+/+ or Il27ra/ mice were 
stimulated with plate-bound anti-CD3 and soluble anti-CD28 under TH0 
polarizing conditions and in the presence or absence of 20 ng/ml rmIL-27 
for the times indicated. Il21 mRNA was determined by real-time RT-PCR 
and is presented relative to rpl19 mRNA. Data represent the mean of trip-
licate experimental samples and error bars indicate standard deviation.  
(B) CD4+ T cells isolated from C57BL6 spleens were stimulated as in A (n.t., 
no treatment) and IL-21 protein was measured in the culture supernatant 
by ELISA. Error bars indicate standard deviation. (C) FACS-purified 
CD4+CD45RA+CXCR5 cells from human tonsil were labeled with CFSE 
and stimulated with anti-CD3 + anti-CD28 + anti-CD2 beads (2:1 ratio of 
beads to cells) in the presence of no additional cytokine, 20 ng/ml rhIL-12 
or IL-23, or 50 ng/ml rhIL-27 for 5 d. IL-21 expression was assessed by 
intracellular staining and flow cytometry and is plotted against CFSE divi-
sion. The percentage of IL-21–expressing cells is indicated. Similar data 
were obtained from three individuals. (D) Naive CD4+ T cells were FACS 
purified from three healthy controls and three AD-HIES patients and 
stimulated as in C. The mean percentage of IL-21+ cells ± SEM is given.  
(E) Groups of Il27ra+/+ (filled circles) and Il27ra/ (open squares) mice 
were immunized with OVA (30 µg/mouse) in CFA. 4 and 8 d after immuni-
zation, CD4+ T cells were isolated from the spleens and IL-21 mRNA was 
determined by real time RT-PCR (relative to rpl19). Data from individual 
animals are shown. Bars indicate the mean of five animals ± SEM.  
*, P < 0.05; ***, P < 0.001 (unpaired Student’s t test). One of three (A and B) or 
two (E) independent experiments is shown. C shows a single donor repre-
sentative of six. D shows data combined from three independent donors.JEM VOL. 207, December 20, 2010 
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antibody. However, a similar requirement for Il27ra was ob-
served 7 d after a single immunization (Fig. S2, C and D; and 
not depicted)
We reproducibly noted a significantly reduced popula-
tion of TFH cells in both the spleen and DLN of Il27ra/ 
mice; however, we consistently saw that the magnitude of 
the reduction was greatest in the spleen (Fig. 2 and Fig. S2). 
Inhibition of lymphocyte migration using FTY720 adminis-
tration did not prevent the tissue-specific effect (Fig. S2 C), 
suggesting  that  IL-27–dependent  lymphocyte  migration  is 
not responsible for these tissue-specific differences. Further-
more, although blockade of IL-21 using a soluble IL21R-Fc 
molecule diminished the percentage of CXCR5+PD1+ cells 
in WT mice, particularly in the LN, it was unable to further 
suppress TFH cell numbers in Il27ra/ mice (Fig. S2 D), sug-
gesting that these two cytokines work in the same pathway.
Reduced GC activity in the absence of Il27ra
Mouse strains that have a deficiency of IL-21 or TFH cells also 
display abortive GC reactions (de Vinuesa et al., 2000; Nurieva 
et al., 2008; Vogelzang et al., 2008). Thus, to confirm that 
TFH cell function was diminished, we examined the forma-
tion of GC in the spleens of immunized Il27ra/ mice. Flow 
cytometric analysis showed that significantly fewer Fas+GL7+ 
GC B cells were present in the absence of Il27ra signaling 
work together to enhance IL-21 production. Indeed, IL-12 
and IL-27 had an additive effect on IL-21 secretion by murine 
CD4+ T cells (Fig. S1 C).
A prominent feature of IL-27 signaling is the activation of 
STAT1; however, induction of IL-21 protein expression was 
not dependent on activation of this transcription factor because 
IL-27 was able to induce IL-21 expression by STAT1/ CD4+ 
T cells (Fig. S1 D). To investigate the importance of STAT3 
activation for IL-27–induced IL-21 expression, we used naive 
CD4+ T cells from autosomal dominant hyper IgE syndrome 
(AD-HIES)  as  a  result  of  dominant-negative  mutations  in 
STAT3 (Minegishi et al., 2007). The addition of rhIL-27 during 
the stimulation of AD-HIES CD4+ T cells could no longer   
induce IL-21 expression (Fig. 1 D), indicating that the induction 
of IL-21 by IL-27 is STAT3 dependent.
Having established that IL-27 is sufficient to induce IL-21 
production in vitro, we next sought to determine whether IL-27 
signaling is required for IL-21 induction in vivo. To this end, 
we immunized WT and Il27ra/ mice with OVA/CFA and 
measured Il21 mRNA expression in splenic CD4+ T cells   
4 and 8 d after immunization. CD4+ T cells from Il27ra/ 
mice contained significantly diminished levels of Il21 mRNA, 
demonstrating that IL-27 signals are nonredundant for IL-21 
expression in vivo (Fig. 1 E). High levels of IL-21 mRNA ex-
pression by WT cells at day 4 compared with day 8 may reflect 
IL-21 expression by recently activated CD4+ T cells in addi-
tion to the fully differentiated TFH cells (King, 2009).
TFH cells are reduced in the absence of Il27ra
Because Il27ra/ mice had reduced IL-21 expression, and 
because IL-21 is both a differentiation factor for and hallmark 
cytokine of TFH cells (Nurieva et al., 2008; Vogelzang et al., 
2008; Eddahri et al., 2009; Yu et al., 2009a; Linterman et al., 
2010), we investigated whether these mice had a reduced 
TFH cell population. To this end, we immunized mice twice 
with TNP-OVA in Freund’s adjuvant and analyzed CD4+  
T cell phenotypes in spleen and LNs 7 d after the second im-
munization. A statistically significant reduction in both the 
percentage and absolute number of PD1+CXCR5+CD4+  
T cells was observed in the spleens and draining LN (DLN) 
of Il27ra/ mice (Fig. 2). To ensure proper discrimination 
between TFH and activated T cells, we stained with addi-
tional markers and found that Il27ra/ mice have a reduc-
tion  in  CD4+  T  cells  with  a  CXCR5+,  PD1+,  ICOS+, 
CCR7lo, CD62Llo, and CD127lo cell phenotype (Fig. S2 A), 
a population matching the published phenotype of TFH cells. 
Interestingly, more ICOS+ cells were observed in the LN 
compared with spleen, both in the CXCR5-positive and   
-negative gates, suggesting that there may be differences in   
the phenotype or activation level of CD4+ cells in the DLN 
(Fig. S2 A). Although the percentage of TFH cells was not signif-
icantly different between WT and Il27ra/ mice before   
immunization (Fig. 2 B), we used a double immunization strat-
egy to ensure that the response to immunization overcame any 
small baseline differences in TFH cell numbers and to provide 
sufficient opportunity for the development of high-affinity 
Figure 2.  Il27ra/ mice contain fewer TFH cells than Il27ra+/+ mice. 
Groups of Il27ra+/+ and Il27ra/ mice were immunized twice with TNP-OVA 
in adjuvant and, 7 d after the second immunization, tissue was collected for 
analysis. (A and B) Representative flow cytometric analysis of CXCR5 and 
PD1 expression in the CD4+B220 gate in the spleen (A) and DLN (B). (C) The 
mean percentage ± SEM of CXCR5+PD1+ cells in each spleen or pair of DLN. 
(D) The numbers of CXCR5+PD1+ cells per organ were calculated for spleen 
and DLN by multiplying the percentage obtained by flow cytometry by the 
total cell count per organ. The mean of at least six animals per group is given 
and error bars indicate SEM. *, P < 0.05 (unpaired Student’s t test). These data 
are representative of four individual experiments.2898 IL-27 signaling is required for TFH cell function | Batten et al.
(Harris et al., 1999). In general, antibody derived from GC-
independent responses appears to be unaffected by the loss of 
IL-27 signaling. Previous studies showed that Il27ra/ mice 
displayed normal levels of total serum Ig, with the exception of 
IgG2a (Chen et al., 2000; Miyazaki et al., 2005). In line with 
these observations, we found that the early IgM response to the 
T cell–independent Ag, TNP-Ficoll, was similar in Il27ra+/+ 
and Il27ra/ mice (Fig. 3 H). Collectively, global absence of 
IL-27 receptor results in a reduction in TFH cells, along with 
diminished GC formation and selective reduction of high- 
affinity antibodies, whereas T cell–independent and low-affinity 
antibodies remain largely unchanged.
Defects in TFH and GC function in Il27ra/ mice  
are T cell intrinsic
The observation that IL-27 directly promotes IL-21 expres-
sion by CD4+ T cells suggested that the defect in TFH cell 
number and GC function in Il27ra/ mice could result from 
a T cell–intrinsic defect. However, other cells, including   
B cells, express the IL-27 receptor, and thus it remained for-
mally possible that the TFH defect in Il27ra/ mice was indi-
rect. To discriminate these two possibilities, we generated 
(Fig. 3, A and B). Histological examination showed that   
although Il27ra/ mice did develop some peanut agglutinin 
(PNA)+ structures resembling GC, these were greatly re-
duced in size compared with WT controls (Fig. 3, C and D). 
The PNA-positive GC area per spleen was found to be sig-
nificantly reduced in Il27ra/ mice (Fig. 3 D).
To examine whether this GC defect translated into lower 
serum levels of high-affinity antibodies, we used an established 
model (Roes and Rajewsky, 1993) whereby high-affinity anti-
bodies to the immunizing hapten, TNP, can be measured in 
the serum by virtue of their ability to bind to sparsely hap-
tenated BSA molecules (TNP2-BSA). The level of total (high 
and low affinity) anti-TNP antibody, as detected using TNP28-
BSA, was similar in Il27ra/ and Il27ra+/+ sera (Fig. 3 E). 
However, the level of high-affinity anti-TNP antibodies   
(detected using TNP2-BSA) was reduced in Il27ra/ mice 
compared with WT mice (Fig. 3 F), indicating that affinity 
maturation is compromised in the absence of IL-27 signaling. 
Il27ra/ mice had reduced levels of class-switched high-affinity 
antibodies, including IgG1, IgG2a, IgG2b, and IgG3 (Fig. 3 G), 
but not IgE (not depicted), which is expected because this 
isotype is inhibited by the GC transcription factor Bcl-6 
Figure 3.  GC dysfunction in Il27ra/ mice. Groups of Il27ra+/+ and Il27ra/ mice were immunized twice with TNP-OVA in adjuvant and, 7 d after 
the second immunization, tissues and sera were collected for analysis. (A) Representative flow cytometric analysis for Fas and GL7 expression in the 
splenic B220+CD4 cell gate. (B) The number of GL7+Fas+B220+CD4 cells in the spleen of each mouse was calculated by multiplying the percentage ob-
tained by flow cytometry by the total cell count per organ. The mean of at least six animals per group is given and error bars indicate SEM. (C) Represen-
tative spleen sections stained with PNA (brown) to detect GC. Bars, 250 µm (D) Slide scanning and image analysis software were used to quantify the 
PNA+ area in each of eight spleens per genotype. The mean percentage of PNA+ area is given and error bars indicate SEM. (E–G) ELISA using plates coated 
with 5 µg/ml BSA-TNP28 (E) or BSA-TNP2 (F and G) for analysis of total anti-TNP and high-affinity anti-TNP antibodies, respectively, in the serum of mice 
immunized as in A. Anti-TNP antibodies were detected with either anti–mouse Ig (E and F) or antibodies against specific mouse Ig isotypes (G). (H) Groups 
of Il27ra+/+ and Il27ra/ mice were immunized with 100 µg TNP-Ficoll i.p. and sera were collected 5 d later. Anti–TNP-IgM levels were assessed by ELISA 
as in E and detected using anti–mouse IgM antibodies. Relative anti-TNP antibody concentration is given for each mouse, and bars indicate the group 
mean where n = 6–8. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (unpaired Student’s t test). The data are indicative of three individual experiments.JEM VOL. 207, December 20, 2010 
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However, lack of Il27ra on the transferred CD4+ T cells sig-
nificantly reduced their recovery rates (Fig. S3 E), with a 
corresponding reduction in Fas+GL7+ GC B cells (Fig. S3 F), 
suggesting that IL-27 supports the survival and/or prolifera-
tion of the DO11.10+ cells in a T cell–dependent manner. 
The effect was most striking when DO11.10+.Il27ra+/+ and 
DO11.10+.Il27ra/ cells were transferred into Il27ra/ re-
cipients (Fig. S3 E), which is consistent with the notion that 
the  transferred  DO11.10+.Il27ra+/+  T  cells  have  a  greater 
mixed BM chimeras using Il27ra/ (CD45.2+ and Thy1.2+) 
BM mixed at a 1:1 ratio with congenic Il27ra+/+ (CD45.1+ 
and  Thy1.2+)  BM  and  transferred  into  lethally  irradiated 
Il27ra+/+CD45.1+Thy1.1+ hosts such that Il27ra/ donors, 
WT donors, and remnant WT host T cells could each be dis-
criminated in the reconstituted chimeric mice. In such mice, 
WT and Il27ra/ T cells have the same exposure to the 
mixed population of WT and KO Ag-presenting cells and   
B cells. FACS analysis of the blood of reconstituted chimeric 
mice revealed a similar contribution of both genotypes to   
T and B cell compartments before immunization (Fig. S3,   
A and B), confirming that absence of the Il27ra does not im-
pair repopulation. The chimeric mice were immunized twice, 
and 7 d after the second immunization the contributions   
of  the  WT  and  Il27ra/  cells  to  the  total  CD4+  and 
CD4+CXCR5+PD1+ TFH cell populations were analyzed by 
flow cytometry. In the total CD4+ gate, WT cells contributed 
with somewhat increased frequency after immunization, with 
the WT/KO ratio being 1.644 ± 0.14 (mean ± SEM) in the 
spleen and 1.366 ± 0.088 in the DLN (Fig. 4, A and B). 
However, WT T cells contributed highly disproportionately to 
the PD1+CXCR5+ TFH gate, with a WT/KO ratio of 3.08 ±   
0.3 in the spleen and 2.689 ± 0.26 in the DLN (Fig. 4,   
A and B). These data suggest that Il27ra/ T cells have an in-
trinsic defect in their follicular helper capacity, and this defect 
cannot be compensated for by the presence of WT APC and 
B cells. Because the TFH cell compartment of the mixed chi-
meric mice was comprised mainly of WT cells, GC function 
was restored and the levels of high-affinity class-switched Ig 
were comparable with mice reconstituted with 100% WT 
cells (Fig. S3 C).
To conclusively rule out direct effects of IL-27 on B cells in 
this model, we constructed BM chimeras using B cell–deficient 
µMT BM plus either WT or Il27ra/ BM (at a 80:20 ratio) 
such that all B cells in the resultant chimeras were derived from 
either the WT (control) or the Il27ra/ BM (a B cell–specific 
Il27ra deletion), whereas the majority of non–B cells were de-
rived from WT BM. The absence of IL-27 signaling in the   
B cell compartment alone did not affect the development of 
TFH cells in the spleen or DLN (Fig. 4, C and D). Although the 
µMT chimeras generally produced lower amounts of high- 
affinity IgG compared with mice reconstituted with only WT 
BM, we noted no difference based on the Il27ra genotype of 
the B cells (Fig. 4 E). Thus, absence of IL-27 signaling in the   
B cell compartment alone affected neither the development of 
TFH cells nor the production of high-affinity antibody.
An adoptive transfer system, in which OVA-specific 
Il27ra+/+ or Il27ra/ DO11.10 transgenic (Tg) CD4+ T cells 
were injected into either Il27ra+/+ or Il27ra/ hosts before 
immunization, further reinforced the T cell–intrinsic nature 
of the GC defect. Although complete removal of IL-27Ra 
from the system recapitulated the Il27ra/ phenotype, as ex-
pected, the percentage of T cells that expressed PD1 and 
CXCR5 was not significantly changed based on donor Il27ra 
genotype (Fig. S3 D). These data suggest that the differentia-
tion of TFH cells can occur in the absence of IL-27 signaling. 
Figure 4.  The GC defect in Il27ra/ mice is T cell intrinsic.  
(A and B) WT (CD45.1+):Il27ra/ (CD45.2+) BM chimeric mice were im-
munized twice with TNP-OVA, as described, and tissue collected and as-
sessed 7 d after the second injection. The ratio of CD45.1/CD45.2 cells is 
given for total CD4+ cells and CD4+CXCR5+PD1+ cells in the spleen (A) or 
DLN (B) for each of 10 chimeric animals. The gray dashed line indicates 
equivalency of WT and Il27ra/ cells (ratio of 1). (C and D) BM chimeric 
mice were reconstituted with BM from WT mice only, Il27ra/ mice only, 
WT and µMT mice (1:4 ratio), or Il27ra/ and µMT mice (1:4 ratio) and 
immunized twice as described. Tissue was collected 7 d after the second 
injection and the percentage of CXCR5+PD1+ cells in the CD4+B220 gate 
in the spleen (C) and DLN (D) was determined by flow cytometry. (E) Serum 
high-affinity antibody was measured using ELISA plates coated with 
TNP2-BSA and detected with anti–mouse IgG antibody. Data are given as 
a relative concentration using pooled serum as a control. Each set of data 
are indicative of two individual experiments. Bars indicate the mean ± SEM. 
*, P < 0.05; **, P < 0.01; ***, P < 0.001 (unpaired Student’s t test).2900 IL-27 signaling is required for TFH cell function | Batten et al.
differentiation. In vitro stimulation of OTII TCR Tg T cells 
in the presence of rmIL-21 resulted in enhanced develop-
ment of GC in adoptive hosts (Nurieva et al., 2008); how-
ever, stimulation with rmIL-27 was not able to enhance B 
helper activity under these conditions (Fig. S4 B). Although 
IL-21 is highly up-regulated by IL-27 stimulation, maximal 
expression appears to reach around 1 ng/ml (Fig. 1 B), which is 
markedly less than the 50 ng/ml IL-21 used in those in vitro 
TFH differentiation systems. Moreover, other consequences 
of IL-27 signaling that diverge from that of IL-21 may also 
contribute to the differences observed. These data suggest 
that although IL-27 enhances the expression of TFH effector 
molecules and cytokines, it is not able to do so in the absence 
of additional signals and is not sufficient to produce fully dif-
ferentiated TFH cells.
In adoptive transfer experiments, IL-27 signaling influ-
enced the amount of Ag-specific CD4+ T cells that were 
present after immunization (Fig. S3, D–F). In in vitro culture 
systems, we noted that the addition of rmIL-27 to Ag-stimu-
lated CD4+ T cells enhanced the survival of these strongly 
stimulated T cells (Fig. 5 B and Fig. S4 C). The survival ad-
vantage conferred to cells by the addition of rmIL-27 was not 
dependent on IL-21R signaling (Fig. S4 D). To investigate 
whether the altered cell survival observed in vitro was re-
flected by changes in TFH cell survival in vivo, we examined 
the percentage of apoptotic (annexin V+) total CD4+ and TFH 
cells in immunized Il27ra+/+ and Il27ra/ mice. We chose a 
time point of 4 d after immunization to examine early changes 
in viability and examined the percentage of annexin V (apop-
totic) cells in the live (7-aminoactinomycin d [7AAD]) gate. 
Although we found that the percentage of annexin V+ cell in 
competitive  advantage  when  the  endogenous  recipient   
T cells, which also participate in the response, are unable to   
respond to IL-27. Alternatively, the increased recovery of 
DO11.10+.Il27ra+/+ T cells from KO hosts might be the result 
of increased IL-27 levels in mice that lack expression of the   
receptor, as is observed in other receptor-deficient mice (Cho 
et al., 2007). Differences between WT and Il27ra/ cells were 
not evident in the LN in the adoptive transfer system (unpub-
lished data). Together, the BM chimera and adoptive transfer 
data described strongly support a T cell–intrinsic defect in GC 
responses in Il27ra/ mice.
IL-27 enhances the expression of TFH cell markers  
and supports CD4+ T cell survival after Ag activation
Our data suggest that IL-27 is important for the differentia-
tion and/or maintenance of TFH cells. To test whether IL-27 
stimulation of CD4+ T cells directly induces differentiation 
of TFH cells, we performed in vitro experiments using OT-II 
Tg T cells. The cells were activated by OVA peptide in the 
presence of irradiated splenocytes and various concentrations 
of rmIL-27 or rmIL-21 for 5 d and then restimulated with 
anti-CD3 for 4 h (RNA expression) or 24 h (protein expres-
sion), as described by Nurieva et al. (2008). Under these con-
ditions, the addition of rmIL-27 resulted in a concentration- 
dependent enhancement of the expression of CXCR5, PD1 
and ICOS mRNA, and proteins on the cell surface (Fig. 5 and 
Fig. S4 A). In our hands, this enhancement was superior to 
rmIL-21. However, when purified CD4+ T cells were stimu-
lated in the absence of accessory cells, ICOS, but not PD1   
or CXCR5, was induced (not depicted; Pot et al., 2009). 
Moreover, IL-27 had little effect on Bcl-6 mRNA expres-
sion (Fig. S4 A), either under the conditions described in this 
paragraph or after a short-term primary stimulation (4 or 24 h; 
not depicted), suggesting that IL-27 did not induce full TFH 
Figure 5.  IL-27 promotes survival of TFH cells.  
(A) OTII Tg CD4+ T cells were cultured with irradiated 
splenic APC plus 0.3 µM OVA323-339 peptide under TH0 
conditions and in the presence of either no additional 
cytokine or various concentrations of rmIL-21 or rmIL-27 
for 5 d. After 5 d, CD4+ T cells were restimulated with anti-
CD3 for 24 h and CXCR5, PD1, and ICOS expression were 
assessed by flow cytometry. The positive gate was deter-
mined based on histogram plots for each antibody and the 
mean percentage positive ± SD for triplicate experimental 
samples is shown. (B) DO11.10 tg.rag2/ splenocytes were 
activated with 0.03 µM OVA323-339 in the presence or ab-
sence (n.t.) of rmIL27 for 72 h, and viability was assessed 
by flow cytometry using annexin V and 7AAD staining. The 
CD4+B220 gate is shown. (C and D) Viability of cells in 
groups of Il27ra+/+ and Il27ra/ mice was assessed by 
flow cytometry 4 d after immunization with TNP-OVA in 
CFA. (C) Representative plots for annexin V staining in the 
CD4+B2207AAD gate (Il27ra+/+, black fill; Il27ra/, gray 
fill) or CXCR5+PD1+CD4+B2207AAD cell gate (Il27ra+/+, 
dotted line; Il27ra/, solid line) in the spleen or DLN.  
(D) The mean percentage of annexin V+ cells in the 
CD4+CXCR5+PD1+7AAD gate. Error bars indicate SEM 
with n = 5 mice per group. Each set of data are  
indicative of two individual experiments. **, P < 0.01  
(unpaired Student’s t test).JEM VOL. 207, December 20, 2010 
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polyclonal  hypergammaglobulinemia,  and 
glomerulonephritis (Satoh and Reeves, 1994; 
Reeves et al., 2009). The IgG hypergamma-
globulinemia and the development of IgG1 
and IgG2a anti-nuclear antibodies appear to 
be dependent on T cell help (Nacionales et al., 
2009). Because genetic factors influence sus-
ceptibility to TMPD-induced lupus, we used 
Il27ra/ mice on the BALB/c background 
to study the importance of IL-27 in the de-
velopment of disease in this model. 42 wk 
after  TMPD  injection,  the  Il27ra/  dis-
played significantly reduced populations of 
TFH and GC B cells (Fig. 6, A and B), along 
with significantly lower levels of serum anti-nuclear (Fig. 6 C) 
and anti-dsDNA IgG (Fig. 6 D) antibodies compared with 
WT controls. Although a global reduction in IgG2a pro-
duction in Il27ra/ mice has been noted previously (Chen 
et al., 2000; Miyazaki et al., 2005), the reduction in anti-
dsDNA antibodies was not confined to this isotype because 
IgG1 anti-dsDNA antibody was also significantly lower in 
Il27ra/ serum (Fig. 6 D). Consistent with the reduction 
in autoantibody production, histological analysis revealed a 
lower  mean  renal  histopathology  score  in  the  Il27ra/ 
mice (Fig. 6, E and F) and a reduction in histological evi-
dence of IgG immune complex deposition in the kidney 
(Fig. 6 G). In both groups, renal lesions consistent with SLE 
are mild, although there was greater individual variability 
with occurrence of more severe lesions in the WT group. 
These data demonstrate that the defects observed in GC 
function in the absence of IL-27 signaling are relevant in 
the disease setting.
the CD4+ T cell pool was similar between WT and Il27ra/ 
mice (Fig. 5 C), the percentage of annexin V+ cells in the 
PD1+CXCR5+  TFH  cell  gate  was  significantly  higher  in 
Il27ra/ spleen and LN compared with WT (Fig. 5, C and D). 
Together, these data suggest that IL-27 is important for the 
survival of TFH cells as well as enhancing the expression of 
TFH cell effector proteins.
Loss of IL-27 signaling ameliorates disease  
in a murine lupus model
Our data suggest that IL-27 might play a pathogenic role in 
diseases that are characterized by affinity-matured autoanti-
body  production  such  as  systemic  lupus  erythematosus 
(SLE; Wellmann et al., 2005; Mietzner et al., 2008). To test 
this hypothesis, we used a model in which a single i.p. in-
jection  of  tetramethylpentadecane  (TMPD;  commonly 
known as pristane) results in an SLE-like syndrome charac-
terized by the development of a variety of autoantibodies, 
Figure 6.  The deletion of Il27ra ameliorates pa-
thology in the pristane-induced lupus model. A single 
0.5-ml i.p. injection of pristane was administered to 
groups of Il27ra+/+ and Il27ra/ mice. 42 wk after induc-
tion, mice were euthanized and examined for immune 
activation parameters and lesions consistent with SLE.  
(A and B) Flow cytometric analysis of splenocytes. The 
percentages of CXCR5+PD1+ (TFH-like) cells in the 
CD4+B220 gate (A) and the percentages of GL7+Fas+  
(GC B cells) in the B220+CD4 gate (B) were analyzed.  
(C) Serum anti-nuclear antibody (ANA). (D) Serum total 
IgG (left), IgG1 (middle), and IgG2a (right) anti-dsDNA 
antibody titers. In all graphs bars indicate mean ± SEM.  
*, P < 0.05; **, P < 0.01; ***, P < 0.001 (unpaired Student’s 
t test). (E and F) Kidney sections were stained with PAS 
and the glomerulopathy scored by blinded observers.  
(E) Mean renal lesion scores are depicted as a box plot 
with max to min whiskers. *, P < 0.05 (unpaired Student’s 
t test). (F) Representative sections. Arrowheads, lumpy 
accumulations of PAS-positive material. Bars, 20 µm.  
(G) Immunofluorescence for IgG immune complex deposi-
tion in the kidney. Lumpy IgG deposits (arrowheads) cor-
respond to PAS positive mesangial deposits. Bars, 50 µm. 
Data represent one experiment with 16 animals per group.2902 IL-27 signaling is required for TFH cell function | Batten et al.
affinity controls TFH differentiation (Fazilleau et al., 2009). 
However, DO11.10+rag2/ T cells that lacked Il27ra were 
recovered at diminished numbers (Fig. S3 E), suggesting that 
IL-27 is important for the maintenance of TFH cells. This hy-
pothesis is supported by our observations that recombinant 
IL-27 enhances the survival of newly activated CD4+ T cells 
in vitro and that TFH cells undergo increased apoptosis in vivo 
when Il27ra is genetically ablated. Although the cells studied 
in vitro were not fully differentiated TFH cells, the death of 
recently activated CD4+ T cells would likely influence the 
number of cells that subsequently become TFH cells. IL-27 
also induced ICOS, and ICOS signals have been shown to 
contribute to the survival and expansion of Ag-specific T cells 
in an immunization system similar to the one used in this 
paper (Burmeister et al., 2008). Thus, although the relative 
contributions remain to be determined, ICOS induction,   
IL-21 production (Nurieva et al., 2008), and other IL-27–
elicited effects may all contribute to the enhanced survival of 
TFH cells.
Somewhat surprisingly, the reduction in TFH cells was 
more pronounced in spleen compared with the DLN (Fig. 2 
and Fig. S2). The transfer of TCR Tg cells confirmed that 
Ag-specific responses occur in the spleen after immunization 
in the flank (Fig. S4, C and D). Because inhibition of lym-
phocyte  migration  using  FTY720  administration  did  not 
prevent  the  tissue-specific  effect  (Fig.  S2  C),  we  favor  a   
hypothesis in which the proximity of the LN to the site of 
injection results in increased local exposure to Ag and inflam-
matory cytokines (Fu et al., 2006). Strong Ag signals pro-
mote TFH differentiation (Vogelzang et al., 2008; Fazilleau   
et al., 2009; Deenick et al., 2010), thus, the dependence on 
IL-27 signals may be reduced. Despite these possible com-
pensatory effects close to the site of immunization, it is clear 
that IL-27 signaling is not redundant because significant re-
ductions in TFH cells in the DLN and reduced serum high-
affinity antibodies remain.
Our data suggest that the TFH-promoting effect of IL-27 
is mediated through direct action on T cells. First, ICOS and 
IL-21 production were induced in T cell–only systems in vitro 
(Fig. 1; Pot et al., 2009). Furthermore, in chimeric animals 
that harbor both WT and Il27ra/ T cells, the Il27ra/  
T cells are selectively underrepresented in the TFH pool (Fig. 4, 
A and B). In contrast, no differences in the TFH response or 
high-affinity Ig levels were noted when Il27ra was selectively 
ablated on B cells (Fig. 4, C and D), which are known to be 
functionally responsive to IL-27 in vitro (Yoshimoto et al., 
2004; Larousserie et al., 2006). These data do not preclude 
the possibility that IL-27 influences certain minor aspects of 
the T cell–dependent humoral response, such as IgG2a class 
switching (Yoshimoto et al., 2004), through direct activities 
on B cells. Although the IL-27R is also expressed on my-
eloid cells, transfer of Il27ra+/+ DO11.10+rag2/ T cells 
into Il27ra/ recipients did not result in a significant de-
crease of TFH differentiation (Fig. S3, D–F), suggesting that 
IL-27 signaling into myeloid cells plays no major role in 
this context.
DISCUSSION
The development of TFH cells is not fully understood and 
represents a topic of intense current interest. Our data posi-
tion IL-27 as a new factor that is critical for TFH cell function. 
Stimulation of T cells with IL-27 promoted IL-21 produc-
tion and expression of the TFH hallmark proteins PD-1, 
CXCR5, and ICOS. In Il27ra/ mice, we observed a re-
duction in IL-21 production, fewer TFH cells, reduced GC 
formation, and a reduction in high-affinity immunoglobulin 
production, indicating that IL-27 signaling is required for ef-
ficient T cell–dependent humoral immune responses. A func-
tional consequence of IL-27Ra ablation was partial protection 
in the pristane-induced lupus model, which is characterized 
by active GC development, production of multiple autoanti-
bodies, and renal pathology. Collectively, these data strongly 
suggest that IL-27 is required for normal and pathogenic GC 
responses in vivo.
IL-27 also induced IL-21 expression by human CD4+  
T cells, suggesting that the IL-27–IL-21 axis is conserved 
across species. However, our results differ from recent obser-
vations by Schmitt et al. (2009), who observed that rhIL-12, 
but not rhIL-27, induced IL-21 expression by human PBMC. 
The reason for this discrepancy remains unresolved at this 
time  but  may  result  from  differences  in  the  experimental 
setup and the strength of TCR stimulation, which we ob-
served to be proportional to IL-21 production (unpublished 
data). Our data also suggest that although IL-12 and IL-27 
can independently induce IL-21 (Fig. 1 C), they can also act 
in concert to induce maximal production of this cytokine 
(Fig. S1, B and C). Mechanistically, IL-21 induction was in-
dependent of STAT1 in murine T cells (Fig. S1 D) but failed 
to occur in STAT3-deficient T cells from human AD-HIES 
patients (Fig. 1 D).
IL-27 was unable to induce the functional TFH phenotype 
in an in vitro system. This was surprising because IL-27 in-
duced IL-21 production, which by itself is sufficient to in-
duce functional TFH cells (Nurieva et al., 2008). However, 
IL-21 levels peak only at 48 h and 1 ng/ml when induced 
by IL-27, whereas direct stimulation with recombinant IL-21 
was conducted at 50 ng/ml and affected cells from the outset 
(Nurieva et al., 2008). Consequently, these two in vitro stim-
ulation experiments cannot be directly compared. Moreover, 
isolated stimulation with a single recombinant cytokine in 
vitro falls short of mimicking the much more complex stimu-
lation environment in vivo, where IL-27 is clearly required 
for a functional TFH response.
In addition to inducing hallmark TFH genes, our data also 
suggest that IL-27 promotes the survival of TFH cells. TFH 
cells represent a highly activated population, which express 
high levels of Fas and low levels of IL-7R (Ma et al., 2009) 
and are exquisitely sensitive to activation-induced cell death 
(Marinova  et  al.,  2006).  In  T  cell  transfer  experiments, 
DO11.10+rag2/ T cells assumed the TFH phenotype read-
ily and independently of IL-27 signaling (Fig. S3 D). This is 
perhaps not surprising because the DO11.10+ cells uniformly 
express  a  high-affinity  Ag-specific  TCR  and  because  Ag   JEM VOL. 207, December 20, 2010 
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were stimulated with OVA323–339 peptide at the indicated concentrations. 
TH0 conditions consist of 5 µg/ml each of hamster anti–mouse IFN- 
(H22),  rat  anti–mouse  IL-4  (BVD4-1D11),  and  rat  anti–mouse  IL-12 
(C15.6) and 100 ng/ml TGFRII-Fc (R&D Systems). Where indicated, 
rmIL-27 was added at a concentration of 20 ng/ml.
Human naive CD4+ T cells were FACS purified from tonsil cell or 
PBMC preparations based on the CD4+CD45RA+CXCR5 phenotype. 
Cells were labeled with CFSE and stimulated with T cell activation and ex-
pansion beads (Miltenyi Biotec) at a bead/cell ratio of 2:1 in the presence of 
no additional cytokine, 20 ng/ml rhIL-12, 20 ng/ml rhIL-23, or 50 ng/ml 
rhIL-27 for 5 d. Where irradiated splenocytes were used as APC, total sple-
nocytes were irradiated with 2,000 rads x-ray irradiation.
Immunization. For T cell–dependent immunization, groups of age- and 
sex-matched mice were immunized with TNP14-OVA (30 µg/mouse) or 
OVA (100 µg/mouse), as indicated, and emulsified in 100 µl CFA (Sigma-
Aldrich) by subcutaneous injection into the flank. Where a second immuni-
zation was required, this was performed 21 d after the initial injection using 
the same dose of Ag emulsified in IFA (Sigma-Aldrich) to a volume of   
100 µl/mouse and injected subcutaneously into the alternate flank.
For T cell–independent immunization, groups of six mice per genotype 
were immunized i.p. with 100 µg TNP-aminoethylcarboxymethyl-Ficoll in 
PBS. Serum was harvested 5 d later.
Flow cytometric analysis. Cells were treated with Fc blocking Abs (anti-
CD16/32 2.4G2) and then surface stained with the specified antibodies.   
To measure cell viability, cells were stained with FITC-conjugated annexin   
V and 7-AAD according to the manufacturer’s instructions (BD). Viable 
cells exclude both stains. IL-21 expression in human T cells was assessed by 
intracellular  staining  using  Alexa  Fluor  647–labeled  anti–human  IL-21 
(eBioscience; clone 3A3-N2). Samples were analyzed using a FACSCanto II 
or LSR II (BD) and data analyzed using Flow Jo software (Tree Star, Inc.). 
Contour profiles are presented as 5% probability contours with outliers.
ELISA. IL-21 was detected in culture supernatants using the mouse IL-21 
DuoSet  ELISA  (R&D  Systems)  as  per  the  manufacturer’s  instructions.   
To measure the relative amounts of TNP-specific antibodies in mouse   
serum,  plates  were  coated  with  5  µg/ml  TNP2-BSA  or  TNP28-BSA   
(Biosearch  Technology)  overnight  at  4°C.  TNP-specific  ELISA  was   
otherwise performed as previously described (Roes and Rajewsky, 1993). 
To standardize and quantify relative amounts of TNP-specific Ig responses, 
all experimental samples were compared with a standardized dilution of 
pooled serum obtained from Il27ra/ mice immunized with TNP-OVA. 
This standard was given the arbitrary concentration of 100. In the case of 
IgM, an anti-TNP monoclonal (BD; clone G155-228) was used as a stan-
dard control.
For serum autoantibody measurement, mouse ANA, anti-Sm, and anti-
nRNP antibodies were measured using ELISA kits from Alpha Diagnostic 
International, as per the manufacturer’s instructions. Anti-dsDNA antibodies 
were measured by coating ELISA plates with 0.01% p-L-Lysine (Sigma- 
Aldrich) for 1 h at room temperature and then 2.5 µg/ml of calf thymus 
DNA (Sigma-Aldrich) in PBS at 4°C overnight. After blocking with PBS, 
0.5% BSA + 10 ppm Procline, pH 7.4, for 1 h at room temperature, serially 
diluted mouse serum was added and incubated at room temperature for 2 h.   
Antibody was detected using 500 ng/ml biotinylated rat anti–mouse IgG, 
IgG1, or IgG2a (BD) for 1 h at room temperature, followed by HRP- 
conjugated streptavidin and visualized using TMB substrate. NZBF1 serum 
was used as a positive control.
BM chimeras. For mixed BM chimeras, triple congenic mice (CD45.1, 
Thy1.1, and IgHa) were lethally irradiated (137Cs; gamma source, 1,150 rad) 
and reconstituted with equal numbers of BM cells from Il27ra+/+ (CD45.1 
and Thy1.2) and Il27ra/ (CD45.2 and Thy1.2) mice by i.v. injection.   
After 8 wk of reconstitution, the mice were bled to assess reconstitution by 
flow cytometry and immunized as described in Immunization.
IL-27 is induced by type I IFN (Pirhonen et al., 2007; 
Remoli et al., 2007), and Ifnar1/ mice display a similar 
phenotype to Il27ra/ mice with respect to both loss of TFH 
function (Cucak et al., 2009) and protection from pristane-
induced lupus (Nacionales et al., 2007), suggesting that IL-27 is 
an important downstream effector of type 1 IFN. In human 
SLE patients, a type 1 IFN signature is readily detectable, and 
antagonists are currently in clinical trails for the treatment   
of this disease (Yao et al., 2009; Niewold et al., 2010).   
Our data suggests that IL-27 might mediate the pathogenic 
effect of type I IFN and that therapeutic targeting of IL-27 
may also be efficacious in SLE and other disorders character-
ized by excessive GC formation and high-affinity autoanti-
body production.
MATERIALS AND METHODS
Mice, cells, and reagents. Il27ra+/+ and Il27ra/ (Chen et al., 2000) mice 
(C57BL/6 background, n > 33 unless otherwise stated or, where indicated, 
BALB/c background, n > 11), OT-II TCR Tg (C57BL6), and Il27ra. 
DO11.10 TCR Tg/rag2-deficient mice (Il27ra/.DO11.10tg.rag2/ or 
Il27ra+/+. DO11.10tg.rag2/ on the BALB/c background) were bred in a 
specific  pathogen-free  facility  at  The  Garvan  Institute  or  Genentech. 
Stat1/ mice (129Sv/Ev background) and 129Sv/Ev control mice were 
purchased from Taconic. The TCM (triple congenic) mice, Igha_B6_
CD45.1_Cross-B6.SJL, which express congenic markers at the CD45.1, 
Igha and Thy1.1 loci on the C57BL6 background, and µMT mice (Igh-
6tm1Cgn targeted mutation; C57BL/6 background) were bred in a specific 
pathogen-free facility at Genentech. The rag2/ animals were purchased 
from The Jackson Laboratory. All live animal experiments were approved by 
the Genentech Institutional Animal Care and Use Committee or The Gar-
van Institute/St. Vincent’s Animal Experimentation Ethics Committee.   
Human PBMC buffy coats were obtained from the Australian Red Cross 
Blood Service, and patients with the clinical diagnosis of AD-HIES as a re-
sult of mutations in STAT3 were recruited from Immunology Clinics in 
Canberra and Sydney, Australia. All human experiments were approved by 
jurisdictional ethics committees in Canberra and Sydney. Unless otherwise 
indicated, all cytokines were purchased from R&D Systems and all anti-
bodies were from BD. Cycloheximide was purchased from Sigma-Aldrich. 
FTY720 (Cayman Chemical) was reconstituted in DMSO and injected i.p. 
in H2O. IL21R-Fc was produced at the Garvan Institute as previously de-
scribed (Herber et al., 2007).
Isolation of lymphocyte subsets. Unless otherwise indicated, primary 
mouse CD4+ T cells were isolated by magnetic depletion using MACS kits 
(Miltenyi Biotec) according to the manufacturer’s instructions. The purity 
ranged from 90 to 95%. Where indicated, FACS sorting was performed   
using a FACSAria instrument (BD) to obtain specific cell populations of >99% 
purity. After immunization, splenic leukocyte populations were isolated as 
follows:  CD4+  (CD4+B220),  TFH  (CD4+CXCR5+PD1+),  non-GC   
B  (B220+CD38+),  GC  B  (B220+CD38lo),  FDC  (B220CD35hiCD32+), 
CD11b+ (CD11b+CD11cB220), and CD11c+ (CD11c+CD11bB220). 
For cell culture systems that required Ag-presenting cells, splenocyte samples 
were magnetically depleted of T cells with anti-CD90 (Thy-1.2) MACS 
MicroBeads (Miltenyi Biotec) and irradiated with a dose of 2,600 rads.
In vitro T cell stimulation. Primary mouse cells were cultivated in   
Iscove’s modified Dulbecco’s medium (Invitrogen) supplemented with 10% 
(volume/volume) heat-inactivated FBS (HyClone PerBio), 1 mM L-glutamine, 
1%  (volume/volume)  penicillin  and  streptomycin  (Invitrogen),  and   
55 µM 2-mercaptoethanol (MP Biomedicals). Splenic CD4+ T cells from 
C57BL/6, Il27ra/, 129, or Stat1/ mice were activated for the indicated 
times in plates coated with 5 µg/ml of anti-CD3 and in the presence of   
1 µg/ml anti-CD28. Unfractionated DO11.10tg.rag2/ or OTIItg splenocytes 2904 IL-27 signaling is required for TFH cell function | Batten et al.
suppress TFH generation in Il27ra/ mice. Fig. S3 shows reconstitution of 
lymphocyte populations and serum levels of high-affinity antibody in BM 
chimeric mice as described in Fig. 4, and it shows TFH and GC B cell gen-
eration when WT or Il27ra/ TCR Tg T cells are transferred to WT or 
Il27ra/ hosts. Fig. S4 details the effect of IL-27 on TFH differentiation 
and T cell survival in vitro. Table S1 is a list of primers and probes used 
for RT-PCR. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20100064/DC1.
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